Scroll Up
Scroll Down
Play Play Play Play
Unregistered User
Click here if this is not your Personal Edition
 
Contact Us | Free E-Mail Updates | Journals | Register a colleague
 
 
Allergy Other
 
   
 
SEARCH   
Doctor's Guide Free CME
Medline
Congress Resource Centre
 

 EXPLORE :
   Most Read News
 All News  All News
 All Webcasts / CME  All Webcasts / CME
 All Cases  All Cases
 Congress Resource Centre  Congress Resource Centre
 All Medical Resources  All Medical Resources
 Medical  My Personal Edition



Warning | Privacy

 

 
 Recent news - Allergy Other
    Ultra-Short Course of Subcutaneous Immunotherapy Well Tolerated in Patients With Seasonal Allergic Rhinoconjunctivitis: Presented at EAACI - (DGDispatch)
    Sublingual Immunotherapy Even More Effective During Pollen Peak Season in Children With Rhinoconjunctivitis: Presented at EAACI - (DGDispatch)
    Children and Adolescents With Grass-Pollen-Allergic Rhinoconjunctivitis Benefit Similarly From 5-Grass Sublingual Monotherapy: Presented at EAACI - (DGDispatch)
    Sublingual Monotherapy Improves Quality of Life in Polysensitised Patients With Allergic Rhinitis: Presented at EAACI - (DGDispatch)
    Recombinant Bet v 1 Sublingual Tablets in Birch Allergy Well Tolerated Up to 50 mcg: Presented at EAACI - (DGDispatch)

    News archive

     Recent webcasts/CME - Allergy Other
    • Alpha1-Antitrypsin Deficiency: Incidence, Screening, and Management
    • Early Detection of Alpha1-Antitrypsin (AAT) Deficiency Helps Prevent Disease Progression
    • What Is the Best Approach to Treating Alpha1-Antitrypsin (AAT) Deficiency?
    • Improving Outcomes for Patients With Allergic Rhinitis: An Update From Philadelphia
    • Recognition and Management of Anaphylaxis

      Webcasts/CME archive

       Recent cases - Allergy Other
        Acute Allergic Reaction due to Milk Proteins Contaminating Lactose Added to Corticosteroid for Injection
        Acute Generalized Exanthematous Pustulosis (AGEP) Triggered by a Spider Bite
        Anaphylactic Reaction to Camomile Tea
        Acute Allergic Interstitial Nephritis After Use of Pantoprazole
        Allergic Enterocolitis and Protein-Losing Enteropathy as the Presentations of Manganese Leak From an Ingested Disk Battery: A Case Report

        Cases archive
          




        my personal edition > allergy other > news
        divider

          E-Mail this DGDispatch to a colleague

        DGDispatch


        Butterbur Extract Appears as Effective as Fexofenadine In Allergic Rhinitis: Presented at EAACI

        By Michael Smith


        AMSTERDAM, THE NETHERLANDS -- June 14, 2004 -- An herbal extract from the leaves of the butterbur plant is at least as effective as is fexofenadine in relieving the symptoms of intermittent allergic rhinitis, say researchers.

        In a poster session at the 23rd Congress of the European Academy of Allergology and Clinical Immunotherapy (EAACI), Andreas Schapowal, MD, PhD, of Landquart, Switzerland, the study's principal investigator, said that
        because the extract is non-sedating, it may be an alternative for patients who can't tolerate the soporific effect of antihistamines.

        The drug – formally known as Ze339 -- "has now been subjected to a series of stringent trials" and deserves to be considered an alternative to traditional anti-histamine therapy, Dr. Schapowal explained.

        Earlier studies, both blinded and controlled, had shown Ze339 was not inferior to cetirizine and was superior to placebo, he said. Dr. Schapowal and his colleagues designed a prospective, double-blind, double-dummy randomized trial with a placebo control to compare Ze339 with fexofenadine.

        The target of the study was the change in symptoms from baseline to end point. Four main symptoms – rhinorrhea, sneezing, itchy nose, and itchy or watery eyes – were recorded.

        As expected, the 107 patients in the placebo group saw little or no improvement in their symptoms. But, patients getting either of the active treatment drugs saw all 4 symptoms improve by more than 35% – a result that is highly statistically significant, at the P =.001 confidence level.

        Both drugs began working quickly -- day 1 for fexofenadine and day 2 for butterbur, results showed.

        In nature, the butterbur plant contains liver-toxic alkaloids, but the variety used to make this extract has very low levels and they are removed during preparation, Dr. Schapowal said.

        The researchers did not observe any serious adverse effects in this study, including elevations of liver enzymes.

        Ze339 "is well-tolerated by patients," he concluded.


        243 - Randomised, double blind, double-dummy, prospective clinical investigation of the efficacy and tolerability of Zeller butterbur extract Ze 339 versus



        E-Mail this DGDispatch to a colleague   To print, use this version






        All contents Copyright (c) 1995-2009 Doctor's Guide Publishing Limited. All rights reserved.



        The NTK initiative. Physicians helping physicians identify Need-To-Know science
           Feedback
        Please rate this article: Strongly DISAGREE...Strongly AGREE NTK logo
        Question 1 - Physicians need to become aware of this information as soon as possible. Question 2 - This information is likely to have an impact on the way physicians practice medicine.
        1
        2
        3
        4
        5
        6
        7
        Send